ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "modifiable risk"

  • Abstract Number: 2376 • 2019 ACR/ARP Annual Meeting

    Modifiable Factors Associated with Response to Treatment in Early Rheumatoid Arthritis

    Zoe Brown 1, Robert Metcalf 2, Jana Bednarz 3, Christiana Stavrou 4, Llewellyn Spargo 2, Michael James 2 and Susanna Proudman5, 1The University of Melbourne, Melbourne, Victoria, Australia, 2Rheumatology Unit, The Royal Adelaide Hospital, Adelaide, South Australia, Australia, 3Adelaide Health Technology Assessment, The University of Adelaide, Adelaide, South Australia, Australia, 4University College London Hospital, London, United Kingdom, 5University of Adelaide, Adelaide, Australia

    Background/Purpose: Among the potentially modifiable prognostic factors in RA, there is evidence for associations with smoking history, BMI and dietary fish oil supplementation. An integrated…
  • Abstract Number: 2982 • 2018 ACR/ARHP Annual Meeting

    Normal Mortality of the Cobra Early Rheumatoid Arthritis Trial Cohort after 23 Years Follow up

    Pomme Poppelaars1, Lilian van Tuyl2 and Maarten Boers1,3, 1Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 3Epidemiology & Biostatistics, Epidemiology & Biostatistics | VU University Medical Center, Netherlands, Amsterdam, Netherlands

    ACR abstractBackground/Purpose: Mortality in patients with rheumatoid arthritis (RA) is higher than in the general population. In most studies this becomes apparent only after more…
  • Abstract Number: 1141 • 2018 ACR/ARHP Annual Meeting

    Trajectories of Extensive Sitting and Associated Predictors in Persons at High Risk for Knee Osteoarthritis

    Julia (Jungwha) Lee1, Alison H. Chang2, Orit Almagor2, Joan S. Chmiel3, Karen W. Hayes2, C. Kent Kwoh4 and Leena Sharma5, 1Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Medicine, Division of Rheumatology, University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ, 5Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose:  Too much sitting has been recognized as a major public health issue. However, it is unknown if distinctive patterns of extensive sitting over time…
  • Abstract Number: 2134 • 2018 ACR/ARHP Annual Meeting

    Modifiable Risk Factors and the Development of Psoriatic Arthritis in People with Psoriasis

    Amelia Green1,2, Gavin Shaddick3, Rachel Charlton1, Julia Snowball1, Alison L Nightingale1, Catherine Smith4, William Tillet1,5 and Neil McHugh1,5, 1Department of Pharmacy and Pharmacology, The University of Bath, Bath, United Kingdom, 2Department of Mathematical Sciences, The University of Bath, Bath, United Kingdom, 3Centre for Data Science and Statistics, The University of Exeter, Bath, United Kingdom, 4Guy’s and St Thomas’ NHS Foundation Trust, St John’s Institute of Dermatology, London, United Kingdom, 5Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom

    Background/Purpose: Psoriatic Arthritis (PsA) is a progressive and often destructive joint disease that causes pain, swelling and joint stiffness, and can lead to an impaired…
  • Abstract Number: 1649 • 2016 ACR/ARHP Annual Meeting

    Influence of Modifiable Risk Factors on the Response to MTX Alone in Early RA Patients

    Eugenio Chamizo Carmona1, Carmen Carrasco-Cubero2, Juan Jose Aznar Sánchez3, Raul Veroz Gonzalez3, Tamara Libertad Rodriguez Araya1, Piter José Cossio Jimenez3 and Lara Chaves Chaparro1, 1Rheumatology, Hospital de Mérida, Mérida, Spain, 2Rheumatology, Complejo Universitario de Badajoz, Badajoz, Spain, 3Hospital de Mérida, Mérida, Spain

    Background/Purpose: The aim of early RA treatment is remission. Intensive treatment with MTX and treat-to-target approach achieve remission in 30-50% patients. Modifiable risk factors, as…
  • Abstract Number: 1410 • 2014 ACR/ARHP Annual Meeting

    Low Rates of Cardiovascular Risk Factor Modification Among High-Risk Rheumatoid Arthritis Patients: Barrier to Cardiovascular Prevention Strategies?

    Kimberly P. Liang1, Rohit Aggarwal2, Juan (June) Feng3, Jason Lyons3, Heather Eng3, Stephen R. Wisniewski3, Melissa Saul4, Douglas P. Landsittel5, Douglas W. Chew1, Aryan Aiyer6 and Larry W. Moreland7, 1Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Medicine, University of Pittsburgh, Pittsburgh, PA, 3Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 4Biomedical Informatics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, 5Medicine, Biostatistics and Clinical and Translational Science, University of Pittsburgh, Center for Health Care Research Data Center, Pittsburgh, PA, 6Department of Medicine, Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA, 7Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose:   Despite higher risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA), systematic cardiovascular (CV) prevention strategies are lacking. Recent guidelines for CV risk…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology